References
- Amberson W. R. Substitutes for blood. Biol. Rev. 1937; 12: 48–86
- Arstall M. S., Kelly R. A. The role of nitric oxide in heart failure. Coronary Artery Dis. 1999; 10(5)301–308
- Bernstein R. D., Ochoa F. I., Xu X., Forfia P., Shen W., Thompson C. I., Hintze T. H. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ. Res. 1996; 79: 840–848, [PUBMED], [INFOTRIEVE]
- Boveris A., Costa L. E., Poderoso J. J., Carreras M. C., Cadenas E. Regulation of mitochondrial respiration by oxygen and nitric oxide. NY Academy of Sci. 2000; 899: 121–135
- Buja L. M., Ferrans V. J., Mayer R. J., Roberts W. C., Henderson E. S. Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 1973; 32(4)771–788, [PUBMED], [INFOTRIEVE]
- Buja L. M., Ferrans V. J., Roberts W. C. Drug-induced cardiomyopathies. Adv. Cardiol. 1974a; 13: 330–348, [PUBMED], [INFOTRIEVE]
- Buja L. M., Ferrans V. J., Rabson A. S. Letter: Unusual nuclear alterations. Lancet March 9, 1974b; 1(854)402–403
- Burhop K. E., Estep T. E. Hemoglobin-induced myocardial lesions. Artif Cells, Blood Subs, and Immob Biotechnology 2001; 29(2)101, Abstract II-4
- Chatterjee R., Welty E. V., Walder R. Y., Pruitt S. L., Rogers P. H., Arnone A., Walder J. A. Isolation and characterization of a new hemoglobin derivative cross-linked between the α chains (Lysine 99α1–Lysine 99α2). J Biol Chem. 1986; 261(21)9929–9937, [PUBMED], [INFOTRIEVE]
- Doherty D. H., Doyle M. P., Curry S. R., Vali R. J., Fattor T. J., Olson J. S., Lemon D. D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nature Biotechnology 1998; 16: 672–676, [PUBMED], [INFOTRIEVE], [CROSSREF]
- FDA. Summary Basis of Approval. 1973, NDA 17-395, Intropin® (Dopamine Hydrochloride) Injection
- Haft J. I. Cardiovascular injury induced by sympathetic catacholamines. Prog. Cardio. Vas. Dis. 1974; 17: 73–85, [CROSSREF]
- Henry Y., Guissani A. Interactions of nitric oxide with hemoproteins: roles of nitric oxide in mitochondria. Cell. Mol. Life Sci. 1999; 55(8–9)1003–1014, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Linden J. V., Bianco C. Blood Safety and Surveillance. Marcel Dekker Inc., New York 2001; pp. 1–445
- Moreno M., Jr., Nathan L. P., Metze K., Costa S. K., Antunes E., Hyslop S., Zatz R., de Nucci G. Non-specific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat. Clin. Exp. Pharmacol. & Physiol. 1997; 24: 349–352
- Ono Y., Ono H., Matsuoka H., Fugimori T., Frohlich E. D. Apoptosis, coronary arterial remodeling and myocardial infarction after nitric oxide inhibition in SHR. Hypertension 1999; 34: 609–616, [PUBMED], [INFOTRIEVE]
- Patel R. P. Biochemical aspects of the reaction of haemoglobin and NO: Implications for Hb-based blood substitutes. Free Radical Bio. & Med. 2000; 28(10)1518–1525, [CROSSREF]
- Shen W., Xu B. X., Oxhoa M., Zhao G., Wolin M. S., Hintze T. H. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ. Res. 1994; 75: 1086–1095, [PUBMED], [INFOTRIEVE]
- Snyder S. R., Welty E. V., Walder R. Y., Williams L. A., Walder J. A. HbXL99α: a hemoglobin derivative that is cross-linked between the α subunits is useful as a blood substitute. Proc. Natl. Acad. Sci. USA 1987; 84: 7280–7284, [PUBMED], [INFOTRIEVE]
- Walder J. A., Zaugg R. H., Walder R. Y., Steele J. M., Klotz I. M. Diaspirins that cross-link β chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate. Biochem. 1979; 18(20)4265–4270
- Zaugg R. H., Walder J. A., Walder R. Y., Steele J. M., Klotz I. M. Modification of hemoglobin with analogs of aspirin. J. Biol. Chem. 1980; 255(7)2816–2821, [PUBMED], [INFOTRIEVE]
- Zhao G., Bernstein R. D., Hintze T. H. Nitric oxide and oxygen utilization: exercise, heart failure and diabetes. Coronary Artery Dis. 1999; 10(5)315–320